A Glutamatergic Model of ECT-induced Memory Dysfunction

References

• Summers W K, Robins E, Reich T. The natural history of acute organic mental syndrome after bilateral electroconvulsive therapy. Biol Psychiatry 1979; 14: 905–12
   Google Scholar
• Sackeim H A, Portnoy S, Neeley P, Steif B L, Decina P, Malitz S. Cognitive consequences of low-dosage electroconvulsive therapy. Ann N Y Acad Sci 1986; 462: 326–40
   PubMed Web of Science ®Google Scholar
• Calev A, Cohen R, Tubi N, Nigal D. Disorientation and bilateral moderately suprathreshold titrated ECT. Convuls Ther 1991; 7: 99–110
   Google Scholar
• Daniel W F, Crovitz H F. Recovery of orientation after electroconvulsive therapy. Acta Psychiatr Scand 1982; 66: 421–8
   PubMedGoogle Scholar
• Figiel G S, Coffey C E, Djang W T. Brain magnetic resonance imaging findings in ECT-induced delirium. J Neuropsychiatry Clin Neurosci 1990; 2: 53–8
   PubMedGoogle Scholar
• Steif B L, Sackeim H A, Portnoy S, Decina P, Malitz S. Effects of depression and ECT on anterograde memory. Biol Psychiatry 1986; 21: 921–30
   PubMed Web of Science ®Google Scholar
• Calev A, Nigal D, Shapira B, Tubi N, Chazan S, Ben-Yehuda Y, et al. Early and long-term effects of electroconvulsive therapy and depression on memory and other cognitive functions. J Nerv Ment Dis 1991; 179: 526–33
   Google Scholar
• Squire L R, Slater P C, Miller P L. Retrograde amnesia and bilateral electroconvulsive therapy. Arch Gen Psychiatry 1981; 38: 89–95
   PubMed Web of Science ®Google Scholar
• Squire L R. Memory and brain. Oxford University Press, New York 1987
   Google Scholar
• Squire L R, Slater P C. Electroconvulsive therapy and complaints of memory dysfunction: a prospective three-year follow-up study. Br J Psychiatry 1983; 142: 1–8
   PubMed Web of Science ®Google Scholar
• Freeman C PL, Kendell R E. ECT I: Patients' experiences and attitudes. Br J Psychiatry 1980; 137: 8–16
   PubMed Web of Science ®Google Scholar
• Taylor J R, Tompkins R, Demers R, Anderson D. Electroconvulsive therapy and memory dysfunction: is there evidence for prolonged defects?. Biol Psychiatry 1982; 17: 1169–93
   PubMed Web of Science ®Google Scholar
• Weeks D, Freeman C PL, Kendell R E. ECT III: Enduring cognitive deficits?. Br J Psychiatry 1980; 137: 26–37
   PubMed Web of Science ®Google Scholar
• Weiner R D, Rogers H J, Davidson J R, Kahn E M. Effects of electroconvulsive therapy upon brain electrical activity. Ann N Y Acad Sci 1986; 462: 270–81
   PubMedGoogle Scholar
• Weiner R D, Rogers H J, Davidson J R, Squire L R. Effects of stimulus parameters on cognitive side effects. Ann N Y Acad Sci 1986; 462: 315–25
   PubMed Web of Science ®Google Scholar
• D'Elia G. Unilateral electroconvulsive therapy. Acta Psychiatr Scand Suppl 1970; 215: 1–98
   PubMedGoogle Scholar
• Lancaster N P, Steinert R R, Frost I. Unilateral electroconvulsive therapy. J Ment Sci 1958; 104: 221–7
   Google Scholar
• Sackeim H A, Prudic J, Devanand D P, Kiersky J E, Fitzsimons L, Moody B J, et al. Effects of stimulus intensity and electrode placement on the efficacy and cognitive side effects of electroconvulsive therapy. N Engl J Med 1993; 328: 839–46
   PubMed Web of Science ®Google Scholar
• Shapira B, Calev A, Lerer B. Optimal use of electroconvulsive therapy: choosing a treatment schedule. Psychiatr Clin North Am 1991; 14: 935–46
   Google Scholar
• Sackeim H, Decina P, Prohovnik I, Malitz S. Seizure threshold in electroconvulsive therapy: effects of sex, age, electrode placement, and number of treatments. Arch Gen Psychiatry 1987; 44: 355–60
   PubMed Web of Science ®Google Scholar
• Sackeim H A, Devanand D P, Prudic J. Stimulus intensity, seizure threshold, and seizure duration: impact on the efficacy and safety of electroconvulsive therapy. Psychiatr Clin North Am 1991; 14: 803–43
   PubMed Web of Science ®Google Scholar
• Krueger R B, Sackeim H A, Gamzu E R. Pharmacological treatment of the cognitive side effects of ECT: a review. Psycho-pharmacol Bull 1992; 28: 409–24
   Google Scholar
• Levin Y, Elizur A, Korczyn A D. Physostigmine improves ECT-induced memory disturbances. Neurology 1987; 37: 871–5
   Google Scholar
• Andrade C, Rao N S, Sekhar R V, Rani M A, Venkataraman B V. Relationship between rate of administration of electroconvulsive shocks and rate of learning in rats: implications for the practice of ECT. Convuls Ther 1994; 10: 206–11
   Google Scholar
• Anwyl R, Walshe J, Rowan M. Electroconvulsive treatment reduces long-term potentiation in rat hippocampus. Brain Res 1987; 435: 377–9
   Google Scholar
• Stewart C, Jeffery K, Reid I. LTP-like synaptic efficacy changes following electroconvulsive stimulation. Neuroreport 1994; 5: 1041–4
   PubMedGoogle Scholar
• Stewart C, Reid I. Electroconvulsive stimulation and synaptic plasticity in. the rat. Brain Res 1993; 620: 139–41
   Web of Science ®Google Scholar
• Stewart C A, Reid I C. Ketamine prevents ECS-induced synaptic enhancement in rat hippocampus. Neurosci Lett 1994; 178: 11–4
   Google Scholar
• Cotman C W, Monaghan D T. Anatomical organization of excitatory amino acid receptors and their properties. Adv Exp Med Biol 1986; 203: 237–52
   Google Scholar
• Gloor P. Epilepsy: relationships between electrophysiology and intracellular mechanisms involving second messengers and gene expression. Can J Neurol Sci 1989; 16: 8–21
   Google Scholar
• Monaghan D T, Bridges R J, Cotman C W. The excitatory amino acid receptors: their classes, pharmacology and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol 1989; 29: 365–402
   PubMed Web of Science ®Google Scholar
• Collingridge G L, Bliss T VP. NMDA receptors: their role in long-term potentiation. Trends Neurosci 1987; 10: 288–93
   Web of Science ®Google Scholar
• Cotman C W, Monaghan D T, Ganong A H. Excitatory amino acid neurotransmission: NMDA receptors and Hebb-type synaptic plasticity. Annu Rev Neurosci 1988; 11: 61–80
   PubMed Web of Science ®Google Scholar
• Harris E W, Ganong A H, Cotman C W. Long-term potentiation in the hippocampus involves activation of Af-methyl-D-aspartate receptors. Brain Res 1984; 323: 132–7
   PubMed Web of Science ®Google Scholar
• Nicoll R A, Kauer J A, Malenka R C. The current excitement in long-term potentiation. Neuron 1988; 1: 97–103
   PubMed Web of Science ®Google Scholar
• Olney J W. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 1969; 164: 719–21
   PubMed Web of Science ®Google Scholar
• Olney J W. Inciting excitotoxic cytocide among central neurons. Adv Exp Med Biol 1986; 203: 631–45
   PubMedGoogle Scholar
• McDonald J W, Johnston M V. Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Res Rev 1990; 15: 41–70
   PubMed Web of Science ®Google Scholar
• Choi D W. Excitotoxic cell death. J Neurobiol 1992; 23: 1261–76
   PubMedGoogle Scholar
• Coyle J T, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993; 262: 689–95
   PubMed Web of Science ®Google Scholar
• Dawson V L, Dawson T M, London E D, Bredt D S, Snyder S H. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci USA 1991; 88: 6368–71
   PubMed Web of Science ®Google Scholar
• Nicotera P, McConkey D J, Dypbukt J M, Jones D P. Orrenius S. Ca2 -activated mechanisms in cell killing. Drug Metab Rev 1989; 20: 193–201
   PubMed Web of Science ®Google Scholar
• Siman R, Noszek J C, Kergerise C. Calpain I activation is specifically related to excitatory amino acid induction of hippocampal damage. J Neurosci 1989; 9: 1579–90
   PubMed Web of Science ®Google Scholar
• Olney J W. Excitotoxic amino acids and neuropsychiatric disorders. Annu Rev Pharmacol Toxicol 1990; 30: 47–71
   PubMed Web of Science ®Google Scholar
• Devanand D P, Dwork A J, Hutchinson E R, Bolwig T G, Sackeim H A. Does ECT alter brain structure?. Am J Psychiatry 1994; 151: 957–70
   PubMed Web of Science ®Google Scholar
• Coffey C E, Weiner R D, Djang W T, Figiel G S, Soady S AR, Patterson L J, et al. Brain anatomic effects of electroconvulsive therapy: a prospective magnetic resonance imaging study. Arch Gen Psychiatry 1991; 48: 1013–21
   PubMedGoogle Scholar
• Wasterlain C G, Fujikawa D G, Penix L, Sankar R. Pathophysiological mechanisms of brain damage from status epilepticus. Epilepsia 1993; 34(suppl)S37–53
   Google Scholar
• Halgren E, Stapleton J, Domalski P, Swartz B E, Delgado-Escueta A V, Walsh G O, et al. Memory dysfunction in epilepsy patients as a derangement of normal physiology. Adv Neurol 1991; 55: 385–410
   Google Scholar
• Mathern G W, Leite J P, Pretorius J K, Quinn B, Peacock W J, Babb T L. Children with severe epilepsy: evidence of hippocampal neuron losses and aberrant mossy fiber sprouting during postnatal granule cell migration and differentiation. Dev Brain Res 1994; 78: 70–80
   Google Scholar
• Meldrum B. Physiological changes during prolonged seizures and epileptic brain damage. Neuropaediatrie 1978; 9: 203–12
   PubMedGoogle Scholar
• Cavazos J E, Das I, Sutula T P. Neuronal loss induced in limbic pathways by kindling: evidence for induction of hippocampal sclerosis by repeated brief seizures. J Neurosci 1994; 14: 3106–21
   PubMed Web of Science ®Google Scholar
• Sutula T P, Cavazos J E, Woodard A R. Long-term structural and functional alterations induced in the hippocampus by kindling: implications for memory dysfunction and the development of epilepsy. Hippocampus 1994; 4: 254–8
   PubMed Web of Science ®Google Scholar
• Sommer W. Erkrankung des Ammonshorns als aetiologisches Moment der Epilepsie. Arch Psychiatrie Nervenkrankh 1880; 10: 631–75
   Google Scholar
• Delaney R C, Rosen A J, Mattson R H, Novelly R A. Memory function in focal epilepsy: a comparison of non-surgical, unilateral temporal lobe and frontal lobe samples. Cortex 1980; 16: 103–17
   PubMed Web of Science ®Google Scholar
• Delaney R C, Prevey M L, Mattson R H. Short term retention with lateralized temporal lobe epilepsy. Cortex 1986; 22: 591–600
   Google Scholar
• Loiseau P, Strube E, Broustet D, Battellochi S, Gomeni C, Morselli P L. Learning impairment in epileptic patients. Epilepsia 1983; 24: 183–92
   Google Scholar
• Margerison J H, Corsellis J AN. Epilepsy and the temporal lobes: a clinical, electroencephalographic and neuropathological study of the brain in epilepsy, with particular reference to the temporal lobes. Brain 1966; 89: 499–530
   PubMed Web of Science ®Google Scholar
• Ben-Ari Y. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 1985; 14: 375–403
   PubMed Web of Science ®Google Scholar
• Mouritze Dam A. Hippocampal neuron loss in epilepsy and after experimental seizures. Acta Neurol Scand 1982; 66: 601–42
   Google Scholar
• Sloviter R S, Dempster D W. “Epileptic” brain damage is replicated qualitatively in the rat hippocampus by central injection of glutamate or aspartate but not by GABA or acetylcholine. Brain Res Bull 1985; 15: 39–60
   PubMedGoogle Scholar
• Olney J W, DeGubareff T, Sloviter R S. “Epileptic” brain damage in rats induced by sustained electrical stimulation of the perforant path, II: Ultrastructural analysis of acute hippocampal pathology. Brain Res Bull 1983; 10: 699–712
   Google Scholar
• Sloviter R S. “Epileptic” brain damage in rats induced by sustained electrical stimulation of the perforant path, I: Acute electrophysiological and light microscopic studies. Brain Res Bull 1983; 10: 675–97
   PubMed Web of Science ®Google Scholar
• Laursen H, Gjerris A, Bolwig T G, Barry D I. Cerebral edema and vascular permeability to serum proteins following electroconvulsive shock in rats. Convuls Ther 1991; 7: 237–44
   Google Scholar
• Petito C K, Schaefer J A, Plum F. Ultrastructural characteristics of the brain and blood-brain barrier in experimental seizures. Brain Res 1977; 127: 251–67
   PubMed Web of Science ®Google Scholar
• Scott A L, Douglas R H, Whitfield A, Kendell R E. Time course of cerebral magnetic resonance changes after electroconvulsive therapy. Br J Psychiatry 1990; 156: 551–3
   Google Scholar
• Tsai G, Ragan P, Chang R, Linnoila V MI, Coyle J T. Increased glutamatergic neurotransmission and oxidative stress during alcohol withdrawal. Am J Psychiatry, [In press]
   Google Scholar
• Chen H S, Pellegrini J W, Aggarwal S K, Lei S Z, Warach S, Jensen F E, et al. Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. J Neurosci 1992; 12: 4427–36
   PubMed Web of Science ®Google Scholar
• Pellegrini J W, Lipton S A. Delayed administration of memantine prevents N-methyl-D-aspartate receptor-mediated neurotoxicity. Ann Neurol 1993; 33: 403–7
   PubMed Web of Science ®Google Scholar
• Goldberg M P, Choi D W. Combined oxygen and glucose deprivation in cortical cell culture: calcium-dependent and calcium-independent mechanisms of neuronal injury. J Neurosci 1993; 13: 3510–24
   PubMed Web of Science ®Google Scholar
• Weiss J H, Hartley D M, Koh J, Choi D W. The calcium channel blocker nifedipine attenuates slow excitatory amino acid neurotoxicity. Science 1990; 247: 1474–7
   PubMed Web of Science ®Google Scholar
• Izumi Y, Benz A M, Clifford D B, Zorumski C F. Nitric oxide inhibitors attenuate N-methyl-D-aspartate excitotoxicity in rat hippocampal slices. Neurosci Lett 1992; 135: 227–30
   PubMedGoogle Scholar
• Monyer H, Hartley D M, Choi D W. 21-Aminosteroids attenuate excitotoxic neuronal injury in cortical cell cultures. Neuron 1990; 5: 121–6
   PubMed Web of Science ®Google Scholar
• Kaku D A, Goldberg M P, Choi D W. Antagonism of non-NMDA receptors augments the neuroprotective effect of NMDA receptor blockade in cortical cultures subjected to prolonged deprivation of oxygen and glucose. Brain Res 1991; 554: 344–7
   Google Scholar
• Coyle J T. Excitotoxins. Psychopharmacology: the third generation of progress, H Y Meltzer. Raven, New York 1987; 333–40
   Google Scholar
• Olney J W, Collins R C, Sloviter R S. Excitotoxic mechanisms of epileptic brain damage. Adv Neurol 1986; 44: 857–77
   PubMedGoogle Scholar
• Clifford D B, Olney J W, Benz A M, Fuller T A, Zorumski C F. Ketamine, phencyclidine, and MK-801 protect against kainic acid-induced seizure-related brain damage. Epilepsia 1990; 31: 382–90
   PubMedGoogle Scholar
• Fariello R G, Golden G T, Smith G G, Reyes P F. Potentiation of kainic acid epileptogenicity and sparing from neuronal damage by an NMDA receptor antagonist. Epilepsy Res 1989; 3: 206–13
   Google Scholar
• Lason W, Simpson J N, McGinty J F. Effects of D-(-)-aminophosphonovalerate on behavioral and histological changes induced by systemic kainic acid. Neurosci Lett 1988; 87: 23–8
   Google Scholar
• Fujikawa D G. Neuroprotective effect of ketamine administered after status epilepticus onset. Epilepsia 1995; 36: 186–95
   PubMed Web of Science ®Google Scholar
• Hudson G M, Buterbaugh G G. MK-801 is neuroprotective, but not anticonvulsive, during pilocarpine-facilitated status epilepticus in kindled rats [Abstract]. Soc Neurosci Abstr 1989; 15: 777
   Google Scholar
• Sloviter R S. Decreased hippocampal inhibition and a selective loss of interneurons in experimental epilepsy. Science 1987; 235: 73–6
   PubMed Web of Science ®Google Scholar
• Rogers B C, Barnes M I, Mitchell C L, Tilson H A. Functional deficits after sustained stimulation of the perforant path. Brain Res 1989; 493: 41–50
   Google Scholar
• Ylinen A, Lahtinen H, Sirvio J, Partanen J, Asikainen A, Gulyas A, et al. Behavioural, electrophysiological and his-topathological changes following sustained stimulation of the perforant pathway input to the hippocampus: effect of the NMDA receptor antagonist, CGP 39551. Brain Res 1991; 553: 195–200
   Google Scholar
• Bullock R. Strategies for neuroprotection with glutamate antagonists: extrapolating from evidence taken from the first stroke and head injury studies. Ann N Y Acad Sci 1995; 765: 272–8
   Google Scholar
• Hamm R J, O'Dell D M, Pike B R, Lyeth B G. Cognitive impairment following traumatic brain injury: the effect of pre- and post-injury administration of scopolamine and MK-801. Cogn Brain Res 1993; 1: 223–6
   PubMedGoogle Scholar
• American Psychiatric Association. Task Force on ECT. The practice of ECT: recommendations for treatment, training and privileging. Convuls Ther 1990; 6: 85–120
   Google Scholar
• Staton R D, Enderle J D, Gerst J W. The electroencephalo-graphic pattern during electroconvulsive therapy, IV: Spectral energy distributions with methohexital, innovar and ketamine anesthesias. Clin Electroencephalogr 1986; 17: 203–15
   Google Scholar
• Smith D H, Okiyama K, Gennarelli T A, McIntosh T K. Magnesium and ketamine attenuate cognitive dysfunction following experimental brain injury. Neurosci Lett 1993; 157: 211–4
   PubMed Web of Science ®Google Scholar
• Pfenninger E, Baier C, Claus S, Hege G. Psychometric changes as well as analgesic action and cardiovascular adverse effects of ketamine racemate versus s(-+)-ketamine in subanesthetic doses. Anaesthesist 1994; 43(suppl 2)S68–75
   Google Scholar
• Krystal J H, Karper L P, Seibyl J P, Freeman G K, Delaney R, Bremner J D, et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 1994; 51: 199–214
   PubMed Web of Science ®Google Scholar
• Tsai G, Passani L A, Slusher B S, Carter R, Baer L, Kleinman J E, et al. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry 1995; 52: 829–36
   PubMed Web of Science ®Google Scholar
• Bormann J. Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels. Eur J Pharmacol 1989; 166: 591–2
   PubMed Web of Science ®Google Scholar
• Trube G, Netzer R. Dextromethorphan: cellular effects reducing neuronal hyperactivity. Epilepsia 1994; 35(suppl 5)S62–7
   PubMed Web of Science ®Google Scholar
• Olney J W, Farber N B. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 1995; 52: 998–1007
   PubMed Web of Science ®Google Scholar
• Fix A S, Wozniak D F, Truex L L, McEwen M, Miller J P, Olney J W. Quantitative analysis of factors influencing neuronal necrosis induced by MK-801 in the rat posterior cingulate/ retrosplenial cortex. Brain Res 1995; 696: 194–204
   PubMed Web of Science ®Google Scholar
• Hargreaves R J, Rigby M, Smith D, Hill R G, Iversen L L. Competitive as well as uncompetitive N-methyl-D-aspartate receptor antagonists affect cortical neuronal morphology and cerebral glucose metabolism. Neurochem Res 1993; 18: 1263–9
   PubMed Web of Science ®Google Scholar
• Hargreaves R J, Rigby M, Smith D, Hill R G. Lack of effect of L-687,414 ((+)-ds-4-methyl-HA-966), an NMDA receptor antagonist acting at the glycine site, on cerebral glucose metabolism and cortical neuronal morphology. Br J Pharmacol 1993; 110: 36–42
   PubMed Web of Science ®Google Scholar
• Duval D, Roome N, Gauffeny C, Nowicki J P, Scatton B. SL 82.0715, an NMDA antagonist acting at the polyamine site, does not induce neurotoxic effects on rat cortical neurons. Neurosci Lett 1992; 137: 193–7
   Google Scholar
• Fujikawa D G, Daniels A H, Kim J S. The competitive NMDA receptor antagonist CGP 40116 protects against status epilepticus-induced neuronal damage. Epilepsy Res 1994; 17: 207–19
   Google Scholar
• Loscher W, Honack D. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy: comparison with MK-801 and carbamaz-epine. J Pharmacol Exp Ther 1991; 256: 432–40
   PubMed Web of Science ®Google Scholar
• Loscher W, Honack D. Overadditive anticonvulsant effect of memantine and NBQX in kindled rats. Eur J Pharmacol 1994; 259: R3–5
   Google Scholar
• Wada Y, Hasegawa H, Nakamura M, Yamaguchi N. The NMDA receptor antagonist MK-801 has a dissociative effect on seizure activity of hippocampal-kindled cats. Pharmacol Biochem Behav 1992; 43: 1269–72
   Google Scholar
• Sveinbjornsdottir S, Sander J W, Upton D, Thompson P J, Patsalos P N, Hirt D, et al. The excitatory amino acid antagonist D-CPP-ene (SDZ EEA-494) in patients with epilepsy. Epilepsy Res 1993; 16: 165–74
   PubMed Web of Science ®Google Scholar
• Tortella F C, Robles L, Witkin J M, Newman A H. Novel anticonvulsant analogs of dextromethorphan: improved efficacy, potency, duration and side-effect profile. J Pharmacol Exp Ther 1994; 268: 727–33
   Google Scholar
• Zhou L M, Szendrei G I, Fossom L H, Maccecchini M L, Skolnick P, Otvos L, Jr. Synthetic analogues of conantokin-G: NMDA antagonists acting through a novel polyamine-coupled site. J Neurochem 1996; 66: 620–8
   PubMed Web of Science ®Google Scholar
• Priestley T, Laughton P, Macaulay A J, Hill R G, Kemp J A. Electrophysiological characterisation of the antagonist properties of two novel NMDA receptor glycine site antagonists, L-695,902 and L-701,324. Neuropharmacology 1996; 35: 1573–81
   PubMed Web of Science ®Google Scholar
• Silver H, Geraisy N. Effects of biperiden and amantadine on memory in medicated chronic schizophrenic patients: a double-blind cross-over study. Br J Psychiatry 1995; 166: 241–3
   PubMed Web of Science ®Google Scholar
• Wong M, Moss R L. Patch-clamp analysis of direct steroidal modulation of glutamate receptor-channels. J Neuroendocrinol 1994; 6: 347–55
   Google Scholar
• Sapolsky R M, Krey L C, McEwen B S. Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging. J Neurosci 1985; 5: 1222–7
   PubMed Web of Science ®Google Scholar
• Axelson D A, Doraiswamy P M, McDonald W M, Boyko O B, Tupler L A, Patterson L J, et al. Hypercortisolemia and hippocampal changes in depression. Psychiatry Res 1993; 47: 163–73
   PubMed Web of Science ®Google Scholar
• Armanini M P, Hutchins C, Stein B A, Sapolsky R M. Glucocorticoid endangerment of hippocampal neurons is NMDA-receptor dependent. Brain Res 1990; 532: 7–12
   Google Scholar
• Tsai G, Gastfriend D R, Coyle J T. The glutamatergic basis of human alcoholism. Am J Psychiatry 1995; 152: 332–40
   PubMed Web of Science ®Google Scholar
• Chandler L J, Newsom H, Sumners C, Crews F. Chronic ethanol exposure potentiates NMDA excitotoxicity in cerebral cortical neurons. J Neurochem 1993; 60: 1978–81
   Google Scholar
• Kamei J, Igarashi H, Kasuya Y. Modulation by serotonin of glutamate-induced lethality in mice. Res Commun Chem Pathol Pharmacol 1991; 74: 167–84
   Google Scholar
• Altamura C A, Mauri M C, Ferrara A, Moro A R, D'Andrea D, Zamberlan F. Plasma and platelet excitatory amino acids in psychiatric disorders. Am J Psychiatry 1993; 150: 1731–3
   PubMed Web of Science ®Google Scholar
• Carroll B J, Feinberg M, Greden J F, Tarika J, Albala A A, Haskett R F, et al. A specific laboratory test for the diagnosis of melancholia: standardization, validation, and clinical utility. Arch Gen Psychiatry 1981; 38: 15–22
   PubMed Web of Science ®Google Scholar
• Yehuda R, Boisoneau D, Mason J W, Giller E L. Glucocorticoid receptor number and Cortisol excretion in mood, anxiety, and psychotic disorders. Biol Psychiatry 1993; 34: 18–25
   PubMed Web of Science ®Google Scholar
• Home R L, Pettinati H M, Menken M, Sugerman A A, Varga E, Wilson G F. Dexamethasone in electroconvulsive therapy: efficacy for depression and post-ECT amnesia. Biol Psychiatry 1984; 19: 13–27
   Google Scholar